These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3876726)

  • 1. The immunotherapeutic effect of anti Lyt-1 antibodies on local and metastatic tumor growth.
    Hollander N
    Adv Exp Med Biol; 1985; 186():819-26. PubMed ID: 3876726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of lymphoid and nonlymphoid tumors with monoclonal anti-Lyt-1 antibodies.
    Hollander N
    J Immunol; 1984 Nov; 133(5):2801-5. PubMed ID: 6332862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
    Nakayama E; Uenaka A
    J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subpopulations of mouse Lyt-2+ T cells defined by the expression of an Ly-6-linked antigen, B4B2.
    Fichtner AT; Anderson S; Mage MG; Sharrow SO; Thomas CA; Kung JT
    J Immunol; 1987 Apr; 138(7):2024-33. PubMed ID: 2435788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies.
    Matsuura A; Ishii Y; Yuasa H; Narita H; Kon S; Takami T; Kikuchi K
    J Immunol; 1984 Jan; 132(1):316-22. PubMed ID: 6606669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo.
    Michaelides M; Hogarth PM; McKenzie IF
    Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of two monoclonal anti-Lyt-1 alloantibodies on lymphocyte distribution in vivo.
    Carroll AM; de Sousa M
    Immunology; 1984 Jun; 52(2):325-30. PubMed ID: 6234229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in in vivo distribution and homing of T cell subsets to mucosal vs nonmucosal lymphoid organs.
    Kraal G; Weissman IL; Butcher EC
    J Immunol; 1983 Mar; 130(3):1097-102. PubMed ID: 6600472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
    Suzuki Y; Remington JS
    J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S; Chou T; Rosenberg SA
    Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
    Greenberg PD; Cheever MA; Fefer A
    J Exp Med; 1981 Sep; 154(3):952-63. PubMed ID: 6974221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
    Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice.
    Ozawa H; Iwaguchi T; Kataoka T
    Cancer Immunol Immunother; 1986; 23(1):73-7. PubMed ID: 3533258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
    Greenberg PD; Kern DE; Cheever MA
    J Exp Med; 1985 May; 161(5):1122-34. PubMed ID: 3921652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.